BPC-157 vs TB-500: Two Repair Peptides, Two Different Mechanisms
These two compounds are the most studied "repair" peptides in this literature and are often discussed as if interchangeable. Grouping them together, however, obscures how differently they act and why comparative and combination protocols exist.
Side by side
| BPC-157 | TB-500 (Tβ4) | |
|---|---|---|
| Origin | Synthetic fragment based on a human gastric juice protein | Synthetic version of thymosin beta-4, a natural human peptide |
| Size | 15 amino acids (~1.4 kDa) | 43 amino acids (~4.9 kDa), or active fragment |
| Core mechanism | Cytoprotection, angiogenesis (VEGF), NO-system modulation, fibroblast migration via FAK–paxillin | G-actin sequestration driving cell migration and differentiation |
| Signature models | Tendon/ligament transection, GI mucosal injury (rodent) | Dermal wounds, corneal repair, cardiac injury (rodent; some human ophthalmic trials) |
| Stability | Unusually robust, acid-stable | Standard peptide handling required |
| Human trials | None published | Ophthalmic (Tβ4 eye drops) only |
Why combination protocols use both
Combination protocols appear in the literature and in lab practice because the two peptides act at different layers of the repair cascade. TB-500's actin mechanism affects whether cells can move; migration into a wound bed is actin-dependent by definition. BPC-157's reported effects focus on the local environment those cells enter, including vascularization, growth-factor expression and cytoprotection. In vitro, the distinction maps to different assays: migration/scratch tests for TB-500, and angiogenesis and survival assays for BPC-157.
Which does a given protocol call for?
- Migration-centric questions (scratch assays, chemotaxis) → the actin mechanism, TB-500.
- Vascularization, GI cytoprotection, tendon fibroblast models → BPC-157.
- Comparative or combined-arm designs → the BPC-157 + TB-500 combination vial (10mg + 10mg) keeps molar accounting simple with one certificate covering both compounds.
Full research summaries: BPC-157 overview · TB-500 overview. For research use only — not for human or veterinary use.